| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0081 | 0.9 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |